Agentix (AGTX) EPS (Basic) (QoQ) (2014 - 2026)
Agentix (AGTX) EPS (Basic) (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -52.61% |
| Mar 31, 2026 | 1.89% |
| Dec 31, 2025 | 45.46% |
| Sep 30, 2025 | 22.45% |
| Jun 30, 2025 | -2.23% |
| Mar 31, 2025 | -26.32% |
| Dec 31, 2024 | -58.70% |
| Sep 30, 2024 | 39.84% |
| Jun 30, 2024 | -4,927.25% |
| Mar 31, 2024 | -147.03% |
| Dec 31, 2023 | 103.56% |
| Sep 30, 2023 | 56.30% |
| Jun 30, 2023 | 6.99% |
| Mar 31, 2023 | -21.57% |
| Dec 31, 2022 | 16.84% |
| Sep 30, 2022 | -156.96% |
| Feb 28, 2022 | -1,032.17% |
| Nov 30, 2021 | 31.95% |
| Aug 31, 2021 | -41.08% |
| May 31, 2021 | 75.73% |